Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amniotic tissue-derived factors are a complex mixture of bioactive molecules, including growth factors, cytokines, and enzyme inhibitors, isolated from the human amniotic membrane and associated tissues. These factors collectively contribute to tissue regeneration, immunomodulation, anti-inflammation, angiogenesis, and wound healing. They are not a single target but a combination of factors secreted by cells within the amnion and amniotic fluid.
Multiple mechanisms, including growth factor receptor activation, cytokine modulation, protease inhibition, and extracellular matrix interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amniotic Tissue-Derived Factors (ATDFs).